precision medicine

Trending From ACCC

Precision Medicine in Rural and Underserved Areas: Unique Solutions for Unique Challenges

12/19/2023

Rania Emara

Rania Emara explains the social barriers that socioeconomically affected rural groups experience with precision medicine and provides some insight into possible solutions.

Rania Emara explains the social...

12/19/2023

Journal of Clinical Pathways

News

Utility of Genomic Instability Test Scores for Predicting PARP Response in Ovarian Cancer

06/03/2020

HRD test results used in published and ongoing clinical trials for PARP inhibitor-treatment of ovarian cancer are not equivalent, according to the results of a study presented at the American Society of Clinical...

HRD...

06/03/2020

Journal of Clinical Pathways

Interview

Prior Authorization for Comprehensive Genomic Profiling in Clinical Pathways

05/27/2020

At the Community Oncology Alliance (COA) Annual Meeting (April 24, 2020), Lee Schwartzberg, MD, FACP, West Cancer Center and Research Institute (a member of OneOncology), moderated a stakeholder panel discussion on...

At the...

05/27/2020

Journal of Clinical Pathways

Healthcare Economist

Payer Perceptions of Genomic Precision Medicine

05/20/2020

Jason Shafrin, PhD

Jason Shafrin, PhD, highlights a study that shows which factors payers consider when evaluating whether to provide coverage for genetic tests as well as how they value these factors.

Jason Shafrin, PhD, highlights a...

05/20/2020

Journal of Clinical Pathways

Research in Review

Panel Highlights Uses of Genomic Testing for Breast Cancer

06/07/2017

JCP Editors

A panel of breast cancer experts offered an education session on the value of standard and genomic testing for breast cancer at the 2017 American Society of Clinical Oncology Annual Meeting (June 2-6, 2017; Chicago,...

A...

06/07/2017

Journal of Clinical Pathways

Research in Review

Financial Benefit of NGS Varies by Patient, Disease Type in Community Settings

06/01/2017

JCP Editors

Next-generation sequencing (NGS) may be economically beneficial for select patients with treated in the community oncology setting, but it should be carefully applied due to potential associated financial burdens,...

...

06/01/2017

Journal of Clinical Pathways

Research in Review

Microbiome Signature Helps Predict Prostate Cancer

06/01/2017

JCP Editors

Transcriptome sequencing that identifies pathogens in prostate cancer biopsies can be used as a signature for disease detection, according to research presented at the 2017 ASCO Annual Meeting (June 2-6, 2017;...

...

06/01/2017

Journal of Clinical Pathways

Research in Review

New NGS Platform Better Identifies Targetable Genomic Alterations in Metastatic Cancers

05/31/2017

JCP Editors

A new comprehensive next generation sequencing (NGS) platform is more likely than targeted NGS platforms to identify clinically relevant and actionable molecular alterations in metastatic cancers, according to...

A new...

05/31/2017

Journal of Clinical Pathways

Research in Review

Genomic Analyses Guide Targeted Therapies for Metastatic Cancers

04/07/2017

JCP Editors

High-throughput genomic analyses may improve outcomes in patients with types of metastatic cancer, according to results of a recent trial published in Cancer Discovery (published online April 1, 2017;...

...

04/07/2017

Journal of Clinical Pathways

Research in Review

Rare Form of Colorectal Cancer Responds Well to Precision Medicine

04/06/2017

JCP Editors

Patients with a specific type of metastatic colorectal cancer who are chemotherapy-resistant benefit from treatment with a gene-targeting regimen. ----- Related Content ESMO announces changes to metastatic...

...

04/06/2017

Journal of Clinical Pathways